Tilray Brands

Craft’s off-premise performance over the last four weeks has been a tale of two channels.

Tilray Brands is moving deeper into THC-infused beverages – and getting higher in the process.

Tilray Brands’ 2025 fiscal year ended with mixed results, as the Canadian cannabis and U.S. craft beer platform generated $821.3 million in net revenue ($833.7 million in constant currency) across its various business units for full-year 2025 (FY25, ending May 31, 2025), marking a 4% increase year-over-year (YoY).

Tilray Brands’ cost-cutting measures continue with closure of the Redhook Brewlab in Seattle’s Capitol Hill neighborhood. Chief corporate affairs officer Berrin Noorta told Brewbound that “Redhook Brewlab is now closed as we look for a new location.”

Tilray Brands beverage division president Ty Gilmore is departing from the company, in one of several leadership changes, the craft beverage and cannabis firm announced today. Tilray chief growth officer Prinz Pinakatt is taking over the beverage division, effective immediately.

Tilray Brands chairman and CEO Irwin Simon doesn’t believe the narrative that drinkers – including the youngest legal-drinking-age consumers – are giving up alcohol.

Six of the 10 largest Brewers Association-defined (BA) craft breweries recorded volume declines in 2024, according to data from the trade group’s May/June edition of The New Brewer magazine.

Distributors have become increasingly more pessimistic about beer. But how do they feel about the biggest suppliers and their outlooks for 2025? Investment banking firm Jefferies asked this question in its latest beer distributor survey, which represented portfolios from Tilray (60% of respondents), Constellation (55%), Anheuser-Busch InBev [A-B] (50%), Molson Coors (50%), Boston Beer (40%) and more.

Tilray Brands will cease operations at Hop Valley Brewing in Eugene, Oregon, in July, and transfer production of Hop Valley beers to other breweries owned by the global cannabis and U.S. craft brewing company, Brewbound has learned.

Canadian cannabis giant Tilray Brands recorded a 1% year-over-year (YoY) net revenue decline across all its business ventures in Q3, but the latest financials are simply growing pains as the company continues to streamline and consolidate its business, leadership shared today during the company’s quarterly earnings call with investors and analysts.

In the latest edition of A Round With … – a weekly Q&A with industry leaders exclusively for Insiders – Tilray Brands North America president Ty Gilmore talked with Brewbound’s sibling publication BevNET about how the company intends to leverage its scale to go deep in hemp-derived delta-9 drinks and how it is navigating the evolving regulatory landscape for hemp products in the U.S.

In Wednesday’s Brewbound Newsletter: 🍀 St. Patrick’s Day Off-Premise Dollars -3.9% YoY; 💰 Oregon Proposes 8% Sales Tax for Beer & Wine; 🏟️ Allagash Joins the Mets and Tilray’s Stock Issues; 🌎 The No. 1 Centennial Hop Buyer; 🍊 Sierra Nevada Revamps Big Little Thing IPA.

Tilray Brands is moving large-scale production from Revolver Brewing’s facility in Granbury, Texas, to other facilities, the company confirmed in a statement to Brewbound. Revolver’s Texas location “will continue to operate, focusing on unique and innovative brews, and the taproom will remain open.”

After years of concern that cannabis and THC products could cut into bev-alc occasions, some of the bev-alc industry is starting to view THC-infused beverages as an opportunity. But not everyone is completely on board.